Cancer Research Aziza Shad  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levenson, A. S.
Right arrow Articles by Gartenhaus, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levenson, A. S.
Right arrow Articles by Gartenhaus, R. B.
[Cancer Research 65, 10651-10656, December 1, 2005]
© 2005 American Association for Cancer Research


Priority Reports

MCT-1 Oncogene Contributes to Increased In vivo Tumorigenicity of MCF7 Cells by Promotion of Angiogenesis and Inhibition of Apoptosis

Anait S. Levenson1,2, Kenneth E. Thurn1, Laura A. Simons1, Dorina Veliceasa3, Jennifer Jarrett1, Clodia Osipo2, V. Craig Jordan2,4, Olga V. Volpert2,3, Robert L. Satcher, Jr.1,2 and Ronald B. Gartenhaus5

1 Department of Orthopaedic Surgery and 2 Robert H. Lurie Comprehensive Cancer Center; 3 Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; 4 Fox Chase Cancer Center, Philadelphia, Pennsylvania; and 5 University of Maryland Greenebaum Cancer Center, Baltimore, Maryland

Requests for reprints: Anait S. Levenson, Department of Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, 645 North Michigan Avenue, S 910, Chicago, IL 60611. Phone: 312-503-3670; Fax: 312-908-8479; E-mail: a-levenson{at}northwestern.edu or Ronald B. Gartenhaus, The University of Maryland Marlene and Stewart Greenebaum Cancer Center, 9-011 BRB, 655 West Baltimore Street, Baltimore, MD 21201. Phone: 410-328-3691; Fax: 410-328-6559; E-mail: rgartenhaus{at}som.umaryland.edu.

Overexpression of a novel oncogene MCT-1 (multiple copies in a T cell malignancy) causes malignant transformation of murine fibroblasts. To establish its role in the pathogenesis of breast cancer in humans, we generated stable transfectants of MCF7 breast cancer cells negative for endogenous MCT-1 (MCF7-MCT-1). Overexpression of MCT-1 in these cells resulted in a slight elevation of estrogen receptor-{alpha}, and higher rates of DNA synthesis and growth in response to estradiol compared with the empty vector control (MCF7-EV). The pure antiestrogen fulvestrant inhibited the estradiol-stimulated proliferation of MCF7-MCT-1 cells. The MCF7-MCT-1 clones showed increased invasiveness in the presence of 50% serum compared with the MCF7-EV. In a tumor xenograft model, MCT-1–overexpressing cells showed higher take rates and formed significantly larger tumors than MCF7-EV controls. When we examined angiogenic phenotype and molecular mediators of angiogenesis in MCF7-MCT-1 tumors in vivo, we found greater microvascular density and lower apoptosis in the MCF7-MCT-1 tumors compared with MCF7-EV controls accompanied by a dramatic decline in the levels of angiogenesis inhibitor, thrombospondin-1 (TSP1). In vitro, blocking TSP1 in the medium conditioned by MCT-1–negative cells restored its angiogenic potential to that of the MCF7-MCT-1 cells. Conversely, despite an increase in mRNA encoding vascular endothelial growth factor upon MCT-1 overexpression, vascular endothelial growth factor protein levels have not been notably altered. Taken together, our results suggest that MCT-1 may contribute to the pathogenesis and progression of human breast cancer via at least two routes: promotion of angiogenesis through the decline of TSP1 and inhibition of apoptosis.




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Dai, X. F. Zhao, P. Hagner, P. Shapiro, K. Mazan-Mamczarz, S. Zhao, Y. Natkunam, and R. B. Gartenhaus
Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma
Cancer Res., October 1, 2009; 69(19): 7835 - 7843.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. R. Hagner, K. Mazan-Mamczarz, B. Dai, S. Corl, X. F. Zhao, and R. B. Gartenhaus
Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction
Blood, May 28, 2009; 113(22): 5526 - 5535.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. Kasiappan, H.-J. Shih, K.-L. Chu, W.-T. Chen, H.-P. Liu, S.-F. Huang, C. O. Choy, C.-L. Shu, R. Din, J.-S. Chu, et al.
Loss of p53 and MCT-1 Overexpression Synergistically Promote Chromosome Instability and Tumorigenicity
Mol. Cancer Res., April 1, 2009; 7(4): 536 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Huang, H.-C. Cheng, R. Isom, C.-S. Chen, R. A. Levine, and B. U. Pauli
Protein Kinase C{epsilon} Mediates Polymeric Fibronectin Assembly on the Surface of Blood-borne Rat Breast Cancer Cells to Promote Pulmonary Metastasis
J. Biol. Chem., March 21, 2008; 283(12): 7616 - 7627.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Was, T. Cichon, R. Smolarczyk, D. Rudnicka, M. Stopa, C. Chevalier, J. J. Leger, B. Lackowska, A. Grochot, K. Bojkowska, et al.
Overexpression of Heme Oxygenase-1 in Murine Melanoma: Increased Proliferation and Viability of Tumor Cells, Decreased Survival of Mice
Am. J. Pathol., December 1, 2006; 169(6): 2181 - 2198.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. S. Reinert, B. Shi, S. Nandi, K. Mazan-Mamczarz, M. Vitolo, K. E. Bachman, H. He, and R. B. Gartenhaus
MCT-1 Protein Interacts with the Cap Complex and Modulates Messenger RNA Translational Profiles.
Cancer Res., September 15, 2006; 66(18): 8994 - 9001.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
T. C. Fleischer, C. M. Weaver, K. J. McAfee, J. L. Jennings, and A. J. Link
Systematic identification and functional screens of uncharacterized proteins associated with eukaryotic ribosomal complexes.
Genes & Dev., May 15, 2006; 20(10): 1294 - 1307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.